Abstract:Epigenetic modifications, such as histone post-translational modifications, DNA methylation, and alteration of gene expression by non-coding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), are heritable changes that are independent from the genomic DNA sequence. These regulate gene activities and, therefore, cellular functions. Epigenetic modifications act in concert with transcription factors and play critical roles in B cell development and differentiation, thereby modulating antibody responses to foreign- and self-antigens. Upon antigen encounter by mature B cells in the periphery, alterations of these lymphocytes epigenetic landscape are induced by the same stimuli that drive the antibody response. Such alterations instruct B cells to undergo immunoglobulin (Ig) class switch DNA recombination (CSR) and somatic hypermutation (SHM), as well as differentiation to memory B cells or long-lived plasma cells for the immune memory. Inducible histone modifications, together with DNA methylation and miRNAs modulate the transcriptome, particularly the expression of activation-induced cytidine deaminase, which is essential for CSR and SHM, and factors central to plasma cell differentiation, such as B lymphocyte-induced maturation protein-1. These inducible B cell-intrinsic epigenetic marks guide the maturation of antibody responses. Combinatorial histone modifications also function as histone codes to target CSR and, possibly, SHM machinery to the Ig loci by recruiting specific adaptors that can stabilize CSR/SHM factors. In addition, lncRNAs, such as recently reported lncRNA-CSR and an lncRNA generated through transcription of the S region that form G-quadruplex structures, are also important for CSR targeting. Epigenetic dysregulation in B cells, including the aberrant expression of non-coding RNAs and alterations of histone modifications and DNA methylation, can result in aberrant antibody responses to foreign antigens, such as those on microbial pathogens, and generation of pathogenic autoantibodies, IgE in allergic reactions, as well as B cell neoplasia. Epigenetic marks would be attractive targets for new therapeutics for autoimmune and allergic diseases, and B cell malignancies.

Epigenetic Alterations in Cellular Immunity: New Insights into Autoimmune Diseases

Epigenetic Regulation of B Cells and Its Role in Autoimmune Pathogenesis

Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review

The emerging role of epigenetics in human autoimmune disorders

Advances in Research on Relationship Between DNA Hypomethylation and Systemic Lupus Erythematosus

Dysregulation of epigenetic modifications in inborn errors of immunity

Epigenetic regulation of innate immune dynamics during inflammation

The critical importance of epigenetics in autoimmune-related skin diseases

The Molecular Basis Of Immune Regulation In Autoimmunity

Myeloid-derived suppressor cell: A crucial player in autoimmune diseases

Methylation of T and B Lymphocytes in Autoimmune Rheumatic Diseases

Epigenetic Dysregulation in Autoimmune and Inflammatory Skin Diseases

Epigenetics of Peripheral B-Cell Differentiation and the Antibody Response

Integration of genetic and epigenetic data pinpoints autoimmune specific remodelling of enhancer landscape in CD4+ T cells

Innate and Adaptive Immune Abnormalities Underlying Autoimmune Diseases: the Genetic Connections

New Insights into Epigenetic Regulation of T Cell Differentiation

Exploring the theranostic potentials of miRNA and epigenetic networks in autoimmune diseases: A comprehensive review

Autophagy in immunity: implications in etiology of autoimmune/autoinflammatory diseases.

3D genome organization and epigenetic regulation in autoimmune diseases

The Epigenetics of Lupus Erythematosus

New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease